GLS-1200 Topical Nasal Spray

GLS-1200 topical nasal spray · GeneOne Life Science, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLS-1200 Topical Nasal Spray, covering 2025-07-31 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) [Phase 2]